WallStreetZenWallStreetZen

NASDAQ: ISPC
Ispecimen Inc Earnings Dates, Reports, Calls

Ispecimen earnings were -$10.2M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ISPC earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$2.1M, down 27.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ISPC reported annual earnings of -$11.1M, with 8.3% growth.

ISPC earnings history

Current Revenue
$10.5M
Current Earnings
-$10.2M
Current Profit Margin
-97%

ISPC Return on Equity

Current Company
-115.4%
Current Industry
-12.9%
Current Market
33.7%
ISPC's Return on Equity (-115.4%)... subscribe to Premium to read more.
High Return on Equity Performance

ISPC Return on Assets

Current Company
-72.1%
Current Industry
6%
ISPC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ISPC announces earnings.

ISPC Return on Capital Employed

Current Company
-167.14%
Current Industry
14.1%
ISPC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ISPC vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ISPC-$8.01M-$10.20MN/A-$21.60
APDN-$6.34M-$7.52MN/A-$12.04
MYNZ-$24.62M-$26.30MN/A-$1.62
MDXH-$13.53M-$40.80MN/A-$14.90
NDRA-$9.33M-$9.57MN/A-$39.50

Ispecimen Earnings Reports & History FAQ

What were Ispecimen's earnings last quarter?

On ISPC's earnings call on Invalid Date, Ispecimen (NASDAQ: ISPC) reported Q2 2024 earnings per share (EPS) of -$3.80, up 51.28% year over year. Total ISPC earnings for the quarter were -$2.11 million. In the same quarter last year, Ispecimen's earnings per share (EPS) was -$7.80.

If you're new to stock investing, here's how to buy Ispecimen stock.

Is Ispecimen profitable or losing money?

As of the last Ispecimen earnings report, Ispecimen is currently losing money. Ispecimen's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$10.20 million, a 8.73% decrease year over year.

What was ISPC's earnings growth in the past year?

As of Ispecimen's earnings date in Invalid Date, Ispecimen's earnings has grown year over year. ISPC earnings in the past year totalled -$10.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.